RIGL NASDAQ
Rigel Pharmaceuticals, Inc.
1W: -2.1%
1M: -4.6%
3M: +17.1%
YTD: +12.7%
1Y: +67.4%
3Y: +324.8%
5Y: +26.1%
$47.15
+0.18 (+0.38%)
Weekly Expected Move ±4.4%
$43
$45
$47
$49
$51
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$277M
Revenue
+3.3% YoY
$322M
Net Income
+229.1% YoY
$79M
Free Cash Flow
+20.7% YoY
89.2%
Gross Margin
30.0%
Op. Margin
22.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE126.9%
ROA88.5%
ROIC88.5%
Valuation
P/E2.7
P/B2.1
EV/EBITDA7.6
Leverage
Debt/Equity0.09
Current Ratio1.95
Interest Cov.15.7x
Quality Scores
Piotroski F4/9
Altman Z3.45
Beneish M1.78